Sunshine Guojian Pharmaceutical's (SHA:688336) attributable profit rose 50% year over year to 103.5 million yuan in the third quarter, according to a Wednesday filing with the Shanghai Stock Exchange.
EPS at the drug company increased 55% year over year to 0.17 yuan.
Operating income grew 36% year over year to 342.8 million yuan.
Shares slid 3% during Wednesday's trading.
Price (RMB): ¥22.77, Change: ¥-0.78, Percent Change: -3.31%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.